| Name | Title | Contact Details |
|---|
Áegis Living is a national leader in assisted living and memory care. Providing the finest in senior lifestyle and living options, “We`re the people who make life better” emphasizes health, quality of life, well-being and community. Founded in 1997 and headquartered in Redmond, WA, privately-held Áegis Living operates 30 communities in Washington, California and Nevada, with five currently in development.
Pharma-Med Inc. is a Allentown, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MDC Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
PRS Network is a Larkspur, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.